News about GMP/cGMP

21.01.2021

FDA: Janet Woodcock becomes acting commissioner

Dr. Janet Woodcock has been appointed as acting commissioner of the FDA. The previous commissioner, Dr. Stephen M. Hahn, stepped down from his role at the start of President Biden's term of office.

Janet Woodcock already has a 30-year career at FDA. Most recently, she led the CDER (US FDA Center for Drug Evaluation and Research). Since May 2020, she has also been responsible for leading Operation Warp Speed to support the development of COVID-19 therapeutics. Woodcock will continue to perform this function.  

As she says, she welcomes the challenge of leading FDA on a transitional basis because: 

"The FDA’s public health work is more critical than ever as we continue to fight this global pandemic." 


Sources:

FDA: Janet Woodcock 

Twitter: Janet Woodcock 



Comments

No comment has yet been written about this news


Write your comment about this news